Figures
Abstract
Methanol (MeOH) is considered to be a poison in humans because of the alcohol dehydrogenase (ADH)-mediated conversion of MeOH to formaldehyde (FA), which is toxic. Our recent genome-wide analysis of the mouse brain demonstrated that an increase in endogenous MeOH after ADH inhibition led to a significant increase in the plasma MeOH concentration and a modification of mRNA synthesis. These findings suggest endogenous MeOH involvement in homeostasis regulation by controlling mRNA levels. Here, we demonstrate directly that study volunteers displayed increasing concentrations of MeOH and FA in their blood plasma when consuming citrus pectin, ethanol and red wine. A microarray analysis of white blood cells (WBC) from volunteers after pectin intake showed various responses for 30 significantly differentially regulated mRNAs, most of which were somehow involved in the pathogenesis of Alzheimer's disease (AD). There was also a decreased synthesis of hemoglobin mRNA, HBA and HBB, the presence of which in WBC RNA was not a result of red blood cells contamination because erythrocyte-specific marker genes were not significantly expressed. A qRT-PCR analysis of volunteer WBCs after pectin and red wine intake confirmed the complicated relationship between the plasma MeOH content and the mRNA accumulation of both genes that were previously identified, namely, GAPDH and SNX27, and genes revealed in this study, including MME, SORL1, DDIT4, HBA and HBB. We hypothesized that human plasma MeOH has an impact on the WBC mRNA levels of genes involved in cell signaling.
Citation: Shindyapina AV, Petrunia IV, Komarova TV, Sheshukova EV, Kosorukov VS, Kiryanov GI, et al. (2014) Dietary Methanol Regulates Human Gene Activity. PLoS ONE 9(7): e102837. https://doi.org/10.1371/journal.pone.0102837
Editor: Klaus Roemer, University of Saarland Medical School, Germany
Received: March 17, 2014; Accepted: June 23, 2014; Published: July 17, 2014
Copyright: © 2014 Shindyapina et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. The human microarray data has been deposited to GEO database with accession number GSE58350. The mouse microarray data has been deposited to GEO database with accession number GSE58303.
Funding: This work was supported by the Russian Science Foundation, grants (Nos. 11-04-01152, 12-04-33016, 14-04-00109) from the Russian Foundation for Basic Research and stipend of the President of the Russian Federation for young scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Robert Boyle first described wood spirits, or methanol (MeOH), as the “sowrish spirit” of boxwood pyrolysis in 1661 [1], and its function in plant and animal life has since been unclear. In higher plants, cell wall pectin methylesterase (PME) produces MeOH by pectin demethylation [2]–[9]. Terrestrial atmospheric MeOH emissions come from volcanoes, H2 and CO2 generation within seafloor hydrothermal systems [10]–[12] and biomass combustion. However PME-mediated emissions from plants are most likely the largest source of MeOH in the atmosphere [13]–[15]. MeOH accumulates in a plant's intercellular air space or liquid pool at night when the stomata close, and a large MeOH release can be observed in the morning when the stomata open [8], [16], [17]. Gaseous MeOH was traditionally considered to be a biochemical “waste product” [8], [9]. However, the effects of PME-generated MeOH from plants-emitters on plants-receivers’ were recently studied [2]. These investigations demonstrated that increased MeOH emissions from PME-transgenic or mechanically wounded non-transgenic plants retard the growth of bacterial pathogen Ralstonia solanacearum in neighboring “receiver” plants. This antibacterial resistance is accompanied by the up-regulation of genes that control stress and cell-to-cell communication in the “receiver”. These results suggest that MeOH is a signaling molecule for within-plant and plant-to-plant communications [2].
In humans, MeOH is considered to be a poison because alcohol dehydrogenases (ADHs) can metabolize MeOH into toxic formaldehyde (FA) [18]–[27]. Then FA is oxidized to S-formylglutathione in a reaction that requires reduced glutathione and is mediated by a NAD-dependent FA dehydrogenase or alcohol dehydrogenase 3 (ADH3) [24], [28]. In the next step, thiolase catalyzes the conversion of S-formylglutathione to formic acid, which dissociates to produce formate and a hydrogen ion. The third reaction (formate to CO2 and water) is catalyzed by catalase through a combination with tetrahydrofolate to produce 10-formyl tetrahydrofolate [21], [25], [29]. FA did not accumulate substantially in MeOH-intoxicated humans [29], [30]. Moreover, FA was not detected in blood, urine, or tissues obtained from MeOH-treated animals, and humans poisoned with the alcohol did not have increased FA [22], [24], [30]–[34]. The time needed to semi-transform FA into formic acid was 1–2 minutes in many species, including humans [35], [36]. Recent data have indicated that MeOH and short-lived FA are natural compounds in normal, healthy human individuals [3], [35], [37]–[43]. The endogenous MeOH content was more than 400 times lower than harmful concentrations [44]. Over 50 mg of FA is produced and metabolized in an adult human body every day according to calculations, and an adult human liver metabolize 22 mg of FA per minute [45]. Its content (0.083±0.001 mM) may be detected in the urine of healthy people [46]. The increased production of endogenous FA was recently shown to be a possible marker for progressive senile dementia [46]. The origin of endogenous MeOH in humans has not yet been elucidated, but two sources of this MeOH have been suggested [37], namely, anaerobic fermentation by gut bacteria [47] and certain metabolic processes in which S-adenosyl methionine (SAM) may be transformed into MeOH [48], [49]. SAM is a universal endogenous methyl donor for various methylation reactions, including the methylation of proteins, phospholipids, DNA, RNA and other molecules that take part in the basic mechanisms of epigenetic phenomena. Genome-wide methylation analysis has indicated DNA methylation profiles that are specific for aging and longevity [50]. Moreover, the unmasked DNA methylation landscape shows that DNA obtained from a 103-y-old donor was more unmethylated overall than DNA from the same cell type in a neonate [51]. Differentially methylated genes are strikingly enriched with loci associated with neurological disorders, psychological disorders, and cancers [52]. Protein carboxylmethylation involves the methylation of the COOH group in amino acids, and the reaction is catalyzed by methyltransferases [53]. The carboxyl methyl ester products readily hydrolyze and produce MeOH under neutral and basic pH conditions or by methylesterase [54]–[58]. Protein carboxymethylase is highly localized in the brain and pituitary gland of several mammalian species [54]–[56]. Interestingly, aspartame, which is a widely used synthetic non-nutritive sweetener, is the methyl ester of a dipeptide (N-L-α-aspartyl-L-phenylalanine) that is likely to convert to MeOH with the participation of protein methylesterases [35], [59], [60].
In considering the function of MeOH, it is important to estimate the toxic consequences of exogenous MeOH intake and the production of endogenous MeOH in humans. Because ADHs evolve utilizing MeOH and ethanol (EtOH), EtOH functions as a powerful competitive inhibitor at low concentrations [21]. The enzyme has a strong preference for converting EtOH to acetaldehyde over the conversion of MeOH to FA [61]. A detection of EtOH and MeOH in breaths from the same volunteer cohort suggested that MeOH and EtOH are formed in the body from different substances and/or processes [41]. EtOH protection from FA production may explain the U-shaped curve that describes dependence between alcohol consumption and cardiovascular diseases [62]–[64]. Very low levels of EtOH in the bloodstream would prevent FA production from endogenous and dietary MeOH in humans in accordance with the clinical practice of when to inhibit by EtOH metabolite production after MeOH poisoning [65], [66]. EtOH can be replaced with 4-methylpyrazole (4-MP) as a potent inhibitor of ADH activity because 4-MP has a longer duration of action and apparently fewer adverse effects [35], [67], [68]. To test the role of ADH in maintaining a low MeOH concentration, we recently showed that the intraperitoneal administration of 4-MP resulted in a significant increase MeOH, EtOH and FA concentrations in mouse plasma [47]. Removing the intestine significantly decreased the addition of MeOH to the plasma suggested the gut flora may be involved in endogenous MeOH production. Increased MeOH and EtOH contents in the liver homogenate were observed after 4-MP administration into the portal vein. Thus the ADH in the liver was confirmed as the primary enzyme for metabolizing MeOH. Liver mRNA quantification showed changes in the accumulation of mRNA from genes involved in cell signaling and detoxification processes. Endogenous MeOH has been hypothesized to act as a homeostatic regulator by controlling mRNA synthesis [47].
4-MP intake by healthy women and men also resulted in the significant elevation of endogenous EtOH and MeOH in plasma [69], indicating a high level of MeOH generated by endogenous human sources. These data raise a question whether MeOH is a metabolic waste product or a chemical with specific functions in humans.
Human MeOH-responsive genes (MRGs) were recently identified [3]. The MRGs were discovered in exposed to MeOH HeLa cells lacking ADH [70]–[72], thereby eliminating from the analysis any confounding effects from genes involved in FA and formic acid detoxification. MeOH that is generated by the pectin/PME complex in the gastrointestinal tract of mice induces MRG mRNA regulated accumulation in brain. Mice prefer the odor of MeOH to the odors of other plant volatiles, and MeOH exposure alters MRG mRNA accumulation in the mouse brain. This finding led to the conclusion that the MeOH emitted by wounded plants may have a role in plant-animal signaling. Among the four identified MRGs, the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and sorting nexin 27 (SNX27) of mouse brains exhibited high responsiveness to MeOH intake or pectin/PME complex [pectin(PME+)] ingestion. GAPDH has often been referred to as a “housekeeping” gene and is used to standardize northern blots. However, a number of novel functions for GAPDH beyond glycolysis have been described over the last two decades, including nuclear trafficking, Aβ biogenesis and AD-related apoptosis [73]–[76]. A putative signaling function for MeOH was supported by the simultaneous increase in mSNX27 mRNA synthesis. Recent data showed the involvement of SNX27 in signal transmission [77], [78] and AD pathogenesis [79], [80]. We suggested that plant pectin and PME-generated MeOH could be one of the plant compounds that reduce progress of AD [3].
However, we found complex and unpredictable behavior testing the transcriptional activity of these genes in the WBCs of volunteers who ate the portion of salad. This finding is apparently explained by the presence in the blood plasma of a mixture of MeOH and its metabolites, which is to say that human blood plasma MeOH is converted to FA and formic acid by the ADH and aldehyde dehydrogenase (AlDH) of the liver. Therefore, human WBCs may not only be exposed to MeOH but also to its metabolic products. Thus, the reaction of the transcriptome can be more complex and not limited to the four identified genes.
In the present study, we estimated the level of plasma MeOH production by endogenous sources. Moreover, we conducted whole genome analysis, which revealed the gene responses of healthy volunteer WBCs at the transcriptome level through human genome microarrays. We investigated the gene expression changes between WBC samples of fasted volunteers before and after citrus pectin intake and showed 32 significantly differentially regulated mRNAs. We concluded that human plasma MeOH, which is replenished from endogenous and exogenous sources, has an impact on the WBC mRNA levels of the genes involved in cell signaling.
Results
Pectin and alcohol intake increases MeOH and FA contents in human blood plasma
Human endogenic MeOH is thought to be rapidly consumed during renal and pulmonary excretion and the chain of metabolic transformations involving ADH and AlDH [18]–[27]. FA was considered to be the first toxic product of MeOH metabolic clearance. It is a short-lived molecule that vanishes rapidly in normal human blood [25], [35], [36]. We investigated the conversion dynamics of MeOH to FA regarding the increase the MeOH content in the volunteers’ blood after administering a small amount of citrus pectin, which increases the MeOH content in mouse blood [3]. Figure 1 shows that the MeOH content of the blood increases markedly at 1 hour after citrus pectin intake. The initial FA content was comparable to the MeOH and increased over the two hours of observation. Along with blood from the cubital vein, we selected saliva, which is easily obtained through noninvasive means and thus has great potential for screening large cohorts [81]. Figure S1 shows that the MeOH content in saliva was 20% lower on average than it was in the blood, but the concentration also increased with time.
The dynamics of MeOH and FA changes in blood plasma after administering pectin are shown. Each volunteer took capsules containing citrus pectin (6 g). After 30, 60, 90 and 120 min, blood samples were obtained and analyzed for MeOH and FA content by GC and HPLC, respectively. The inset shows the ethanol concentrations after pectin administration. The standard error bars are indicated. ***P<0.001 (Student’s t-test, n = 8); n.s., not significantly different.
It can be assumed that the ADH-mediated increase in the blood FA content should not affect the endogenous EtOH content because MeOH can displace ADH molecules from the ethanol-to-acetaldehyde conversion. Indeed, volunteers who received citrus pectin exhibited a small but statistically significant increase in EtOH according to the results shown in Figure 1 (inset).
Next, we examined the influence of red wine intake on human plasma MeOH. Red wine is a plant product and source of antioxidants, and it is now regarded as a dietary and preventive means of reducing the risk of cardiovascular and neurodegenerative diseases in humans [82], [83]. However, red wine may influence the MeOH content of the blood. To evaluate the role of red wine as an alcoholic beverage in the human MeOH balance, we evaluated volunteers who drank a glass of red wine (150 ml). A chromatographic analysis of the drink testified that it contained 13.731% EtOH (Fig. S2) and 0.0424% MeOH (Fig. S3). After the volunteers received red wine, blood and saliva were collected and the samples were analyzed by gas chromatography (GC). The MeOH content of the blood (Fig. 2A) and saliva (Fig. S4) increased at 15 minutes after administering the red wine. The increase continued an hour, and then there was a smooth drop in the MeOH content until 120 minutes of observation. Conversely, the amount of FA increased to 90–120 minutes when the MeOH and EtOH level fell (Fig. 2A). The effect of drinking red wine on the MeOH balance is difficult to calculate. On one hand, drinking wine introduces exogenous MeOH (63.6 mg in 150 ml); on the other hand, wine EtOH can increase the pool of endogenous MeOH. Our calculations show that the MeOH contribution from wine was an essential part of its increase in the blood. However, we allowed for the contribution of endogenous MeOH sources because the EtOH in wine can "block" ADH and reduce the "flow" of endogenous MeOH. The accelerated increase in FA levels during the second hour after taking red wine also suggests the involvement of an endogenous pool of MeOH. Endogenous sources of MeOH are not known, but we can assume a high level of production because the MeOH content in the blood is determined primarily by its transformation to FA (metabolic clearance) and also through MeOH removal from the blood by renal and pulmonary excretion. Evaluating the impact of endogenous sources in the MeOH production is possible when the oxidation of MeOH is reduced during ADH competitive inhibition with EtOH. Experiments with volunteers after EtOH intake can assess lower-level MeOH production by endogenous sources because it is difficult to imagine the complete removal of ADH molecules from MeOH metabolism. To conduct this experiment, we selected a group of volunteers (4 males and 4 females) weighing 47 to 90 kg and aged 21 to 67 years. Each volunteer was drinking alcohol on an empty stomach at a volume of 1 ml of 40% EtOH per 1 kg of weight. The alcohol was free of MeOH, as evidenced by GC (Fig. S5). Figure 2B shows that drinking alcohol resulted in increase EtOH and a rapid and almost 6.5-fold increase in plasma MeOH content from 53.3±2.4 to 345.4±49.9 µmol/L in the first 15 min after alcohol administration. The MeOH concentration then remained constant with a slight decrease at the 60-minute point. If we compare these results separately for men and women, a gender difference becomes clear. In women, there was a rise in blood of MeOH during the first 15 minutes, and it increased faster and at a steeper slope than it did in men. Therefore, the MeOH concentration at the 60-minute point was more noticeable but was not statistically significant (Fig. S6). The FA content in the blood of volunteers who drank 40% EtOH increased slowly during the first 60 minutes, rapidly over the next 30 minutes and reached a level of 1.11 mM (33.3 mg/l) at the 120th minute.
Each of the eight volunteers drank 150(13.731% EtOH and 0.0424% MeOH content, respectively) (A) or 40% v/v ethanol (1 ml per kg body weight) (B). After 15, 30, 60, 90 and 120 min, blood samples were collected and analyzed for MeOH, EtOH and FA contents by GC and HPLC, respectively. The data are presented as the means ± SE. Student’s t-test P-values were evaluated to determine the statistical significance of the MeOH, EtOH and FA content differences before and after alcohol intake. ***P<0.001 (Student’s t-test, n = 8); n.s., not significantly different.
We concluded that pectin intake is inevitably accompanied by a marked increase in blood MeOH and toxic FA. Moreover, displacing ADH from MeOH metabolism with alcohol can cause the rapid release of essential amounts of endogenous MeOH and then FA into the blood.
A genome-wide analysis of human WBCs after the ingestion of citrus pectin
To understand the role of endogenous and dietary MeOH in humans, we conducted a full-genome analysis of WBCs in volunteers after administering pectin as a MeOH-generating substance. The WBC transcripts of 18 volunteers who received citrus pectin were analyzed on the Human HT-12 v.4. Expression BeadChip arrays by targeting more than 25,000 annotated genes with more than 48,000 probes. Significant gene expression differences between the samples after pectin intake and the controls were visualized in a cluster diagram (Fig. S7). We identified transcripts that were expressed with detection q-values <0.05 as follows: 106 were up-regulated (Table S1) and 17 were down-regulated (Table S2). Among these results, we selected the genes with the highest gene expression differences (Table 1). Interestingly, (i) there were no detected mRNAs for ADH and NAD-dependent FA dehydrogenase, genes that are involved in the MeOH “detoxifying” metabolism, (ii) most of the identified genes were somehow involved in AD pathogenesis, and (iii) the decreased synthesis of hemoglobin mRNA, HBA and HBB, was revealed. The presence of hemoglobin mRNAs in the WBCs was not a result of contamination with red blood cells because erythrocyte-specific marker genes [107], [108], GYPA, EBP4, SPTA and ALAS2, did not show significant changes. Thus the decreased HBA1 and HBB expression in WBCs did not result from erythropoiesis but from a different mechanism.
Verifying microarray data with qRT-PCR
Microarray data verification was conducted by using WBCs from volunteers after administering pectin or red wine. Oligonucleotide primers for the 7 genes related to oxygen transport (hemoglobin HBB and HBA genes), cell signaling (DDIT4), AD (MME and SORL1) and the earlier identified MRGs (GAPDH and SNX27) were used to validate the microarray data by qRT-PCR. Figure 3 shows the mRNA content changes of WBCs from volunteers after pectin intake. The HBA, HBB, DDIT4, MME and SORL1 genes exhibited complicated dynamic changes in transcript abundance but generally confirmed the microarray assay data (Table 1). The GAPDH and SNX27 genes missing in Table 1 also showed dynamic changes in their mRNA levels after pectin intake.
The influence of citrus pectin intake on human blood leukocyte gene transcription as determined by qRT-PCR. The relative quantities of mRNA after pectin intake were normalized to the mRNA levels before pectin intake. Student’s t-test P-values were calculated by using triplicate blood samples from three volunteers.
Next, we studied how MeOH concentration in the blood plasma correlates with the mRNAs accumulation in WBCs after red wine intake (Fig. 4). In contrast to our expectations, consuming EtOH-containing red wine does not alter the accumulation of mRNAs in the WBCs, which we obtained from volunteers after collecting MeOH-forming citrus pectin.
The relative mRNA quantities after red wine intake was normalized to the mRNA levels before red wine intake. Student’s t-test P-values were calculated by using triple bloods samples of three volunteers.
We concluded that pectin ingestion and red wine intake leads to a change in the MeOH and FA contents of human plasma, which is accompanied by a change in the mRNA abundance of genes involved in cell signaling.
The brain genome-wide analysis of mice after inhalation of vapors of injured plants and of MeOH
The reduced mRNA synthesis of hemoglobin genes in WBCs may be a common reaction of cells to an increase in the plasma levels of MeOH. To test this hypothesis, we conducted a genome-wide analysis of the brain in mice after exposure to methanol vapor under conditions that were close to natural: the mice breathed the vapors from injured plants known to contain methanol [3] (Fig. 5A). RNA samples collected from the mouse brain after inhalation of the wounded plant leaf vapors or MeOH were used to generate cDNA. The brain RNA samples after the inhalation of methanol served as a positive control. The cDNA were analyzed using Illumina Whole-Genome 8 microarrays with probes for approximately 25,600 transcripts. We identified those transcripts that were expressed with P-values of <0.05. Figure 5B shows a Venn diagram of the genes that were differentially expressed after exposure to the vapors from wounded leaves and after methanol inhalation compared with those after the inhalation of water vapor, which served as a negative control. The number and names of the genes (Table S3 and S4) that were regulated by the inhalation of both the vapors from wounded leaves and from methanol are shown in the intersection of the circles (Fig. 5B). Notably, the transcriptional activity of the hemoglobin genes mHBA-A1 and mHBB-B2 (Table S3), which appear to be the genes most sensitive to methanol, is reduced, as in the case of human WBCs (Table 1). The presence of hemoglobin mRNAs in the brain cells was not a result of contamination with red blood cells because the levels of erythrocyte-specific marker genes, including GYPA, EBP4, SPTA and ALAS2, were not significantly expressed. Verification of these microarray data by qRT-PCR showed a dynamic diminution in the transcript abundance of the hemoglobin genes during the first hour after MeOH inhalation (Fig. 6).
(A) Experimental set-up for the inhalation of vapors from wounded leaves by the mice. (B) Venn diagram of the genes that are differentially expressed after the inhalation of methanol and wounded leaf vapors compared with those after the inhalation of water vapor. The genes were analyzed using the J-Express gene expression analysis software. The number of genes commonly regulated is indicated in the intersection of the circles. All the genes (with an average fold-change ≥1.3-fold) included in this analysis showed significant changes in their expression compared with the control, with a Q-value <0.05.
(A) Experimental set-up for the MeOH inhalation by the mice. (B) qRT-PCR analysis of murine brain mRNAs for the hemoglobin genes after methanol inhalation. The data shown represent five independent experiments. ***P<0.001 (Student’s t-test).
We concluded that the inhalation of MeOH vapors led to a change in the mRNA abundance of the mHBA-A1 and mHBB-B2 genes in mouse brain.
Discussion
To assess whether methanol is a friend or foe to humans, we must consider the favorable role of fruits and raw vegetables in human health. Vegetables in the diet are the primary source of exogenous MeOH for a healthy person [3], [109]. The role of MeOH-generating pectin in atherosclerosis and cancer prophylaxis is well-known [110]–[114]. Pectin is believed to affect detoxifying enzymes, stimulate the immune system, modulate cholesterol synthesis and act as an antibacterial, antioxidant or neuroprotective agent [115]. There is also increasing evidence to suggest the regular consumption of fruits and vegetables may play an important role in preventing or delaying the onset of dementia, age-associated cognitive decline and AD [82], [116]–[120].
However, in considering the function of methanol, it is important to estimate the production of endogenous methanol in humans and its toxic metabolites. To study the role of vegetable diet in endogenous methanol generation, we used citrus pectin, which is a dietary supplement. We previously showed that citrus pectin efficiently generates MeOH in the mouse gastrointestinal tract [3]. In this study, we confirmed the ability of citrus pectin to generate MeOH in the human gastrointestinal tract. Two hours after citrus pectin intake (6.0 g), the MeOH content increased by almost two times in volunteer plasma from three independent experiments (Fig. 1). We tried to estimate the level of endogenous MeOH generation by considering the probable removal of MeOH through pulmonary and renal excretion. To estimate the influence of renal clearance on the plasma MeOH balance, we used urine formation parameters for a healthy average ≈70-kg person who consumes alcohol at approximately 60 ml/h, or 0.86 ml/h/kg [22], [121]. Renal MeOH clearance in the average volunteer was measured as 1.0 ml/min or 15 ml per 15 min; it is as if 15 ml of blood was totally cleared of MeOH every 15 minutes. Assuming the average man had a body water content of 60%, and the blood weight accounted for 7% of the body weight we believe that a clearance of 60 ml of blood in 1 hour has little effect on the total MeOH content of the blood. With regards to the pulmonary excretion of MeOH, we used estimates [122] indicating for each minute, 5.6 ml of blood is hypothetically and totally cleared of MeOH, i.e., the effect of pulmonary clearance of plasma MeOH is also negligible. Ignoring the low contribution of renal and pulmonary clearance, we estimated the approximate level of MeOH formation as 116 mg/h by evaluating the endogenous sources of a 70-kg person, i.e., the lower level of endogenous MeOH production is at least ≈1.66 mg/kg/h. Because it seems unlikely that EtOH is able to deplete all of the liver ADH, we should be allowing for a higher level of MeOH production. If we use the lower bound for the formation rate of endogenous MeOH at 1.66 mg/kg/h, then a 70-kg person can form at least 116 mg of MeOH in 1 hour, which is comparable with ingesting 274 ml of red wine.
Elucidating the biological significance of physiological MeOH can help to locate biological and gene targets in WBCs. The potential advantage of blood-based biomarkers is obvious; collecting blood is easier than almost any other body fluid, and blood-based tests lend themselves to high-throughput and inexpensive measurements [123]. There is relatively little evidence available about a transcript signature in the WBCs of AD that might act as a biomarker [124]–[127]. However, the digestion of food by itself has an effect on WBC transcriptional activity [128]–[130]. Thus, to minimize the impact of food intake, we had to provide a small amount of pectin, which leads to MeOH formation in the digestive tract of volunteers.
The identification of human genes, the transcriptional activity of which varies with the blood levels of MeOH, would lie between three possible functions of MeOH in humans as follows: (a) MeOH, a poisonous biochemical waste product, (b) MeOH, a signaling molecule that regulates the activity of human life processes, and (c) a combination of the two above-mentioned mechanisms, that is, MeOH, a Janus-like substance similar to carbon dioxide that is released from the body during respiration, but without which the brain respiration centers cannot be activated [131].
Our microarray analysis of volunteer WBCs after pectin intake showed the various responses of differentially regulated mRNAs (Table 1). Of the 32 genes selected for analysis, 30 were also found to be annotated through the DAVID database service (http://david.abcc.ncifcrf.gov). As shown in the histogram (Fig. S8), half the genes encoded glycoproteins, and their expression is altered with increased blood levels of MeOH. Most of the present genes exhibit increased expression in response to increasing amounts of MeOH (8/15, 53%), and the others are down-regulated (7/15, 47%). Hemoglobin genes exhibit the most pronounced decrease in mRNA synthesis in WBC. This effect is not an artifact and cannot be explained by erythroblast contamination of the WBCs. This finding is supported by our failure to detect the presence of specific erythrocyte gene markers, including GYPA, EBP4, SPTA and ALAS2. Moreover, this reaction is characteristic of cells in general and is not blood-related. Our experiments on animals have shown that the brains of mice exposed to methanol respond by decreasing the levels of hemoglobin gene expression (Fig. 6).
Interestingly, of the 30 proteins analyzed, 8 proteins are receptors, all of which are located in the plasma membrane; 5 of them are up-regulated (68%), and the remaining three are down-regulated (32%). Perhaps this regulation is explained by the increased amount of MeOH in the intercellular space and its impact on these receptors. According to the PANTHER database (http://www.pantherdb.org), 9 of the 32 proteins participated in cell-cell communication processes (Fig. S9). All these findings favor the idea that MeOH concentration changes effect the expression of genes of intercellular communication in WBC. We used the STRING database (http://string-db.org) to analyze possible links between the products of selected genes. The interactions shown in the image (Fig. S10), which was built with a medium confidence parameter (≥0.400), predicted interactions via CD36 between MMP9 and hemoglobins, and among MMP9 and MYC and NCF4. According to KEGG (http://www.genome.jp/kegg/pathway.html), NCF4 and MMP9 are involved in lymphocyte migration, and their interaction is mediated by ROS, such as hydrogen peroxide. In the case of increasing MeOH concentrations in the blood, the expression of NCF4 and MMP9 genes is likely to rise, suggesting their possible positive interaction as induced by MeOH. The relation between MMP9 and MYC is also interesting, as predicted from the KEGG database and the NCI-Nature Pathways Interaction Database. MYC is a known oncogene, and it affects the transcription of a huge number of genes in combination with MAX (Myc-associated factor X, activating complex) and/or MIZ-1 (Myc-interacting zinc finger protein 1, inhibitory complex). As shown in our microarray expression analysis, given an increased amount of MeOH in the blood, the MYC expression in WBC is reduced, whereas MMP9 increased. Perhaps MYC complexes with other proteins and exerts an inhibitory effect on MMP9 expression, whereas the changing amount of MeOH in the blood reduces the level of MYC expression directly or indirectly. Thus, the reduced number of inhibitory complexes with MYC could lead to an increase in the MMP9 expression. In addition to interaction with MMP9, MYC was experimentally demonstrated to directly interact with UBB [132] (Fig. S10).
Thus, our analysis allows us to cede to the third hypothesis, which includes not only the inevitable involvement of MeOH-to-FA toxic metabolite formation but also the participation of MeOH in the regulation of gene transcriptional activity.
Materials and Methods
Volunteer experiments
Eight healthy male and female volunteers between 21 and 67 years of age and within 15% of the normal weight range for their age, height, and frame size were selected for this study. A complete medical history and medical examination, including chest X-ray, electrocardiogram, hematology screening, serum chemistry, and urine analysis, were conducted to assess the health statuses of the volunteers. Exclusion criteria included smoking, obesity, a family history of chronic diseases, any use of medication, heavy physical exercise (10 h/week), pregnancy, and breastfeeding. No subjects had evidence of acute or chronic disease, and all subjects had normal values for the various tests. These studies were approved by the Human Subjects Committee at the N. N. Blokhin National Cancer Research Center, Moscow, Russia (Extract from the Bioethics Commission meeting number 2, on September 20, 2011). Informed consent was obtained from all subjects with written approved consent forms.
Citrus pectin intake.
The subjects fasted for 12 hours prior to beginning each experiment and evaluation session. Each volunteer swallowed capsules with PME containing citrus pectin (6 g) (Nittary Pharmaceuticals, VitaLine, Inc., USA). After 30, 60, 90 and 120 min, blood and saliva samples were obtained and analyzed for methanol and formaldehyde content by GC and HPLC, respectively.
Red wine administration.
The subjects fasted for 12 hours prior to beginning the experiment and evaluation session. Each volunteer drank 150 ml of red wine (13.731% ethanol with 0.0424% methanol content). After 15, 30, 60, 90 and 120 min, blood and saliva samples were collected and analyzed for methanol, ethanol and formaldehyde content by GC and HPLC, respectively.
Alcohol administration.
The subjects fasted for 12 hours prior to beginning the experiment and evaluation session. Each volunteer drank 50–80 ml of 40% alcohol (1 ml per kg of body weight). After 15, 30, 60, 90 and 120 min, blood and saliva samples were collected and analyzed for methanol, ethanol and formaldehyde content by GC and HPLC, respectively.
Human WBC preparation
The blood samples were homogenized with 10 ml of modified Hanks balanced salt solution (Sigma-Aldrich). WBCs were prepared by Ficoll density-gradient centrifugation (Ficoll-Paque PLUS; Amersham) at 300 g for 30 min at 20°C. The ring of high-density WBCs was isolated and washed twice in 50 ml of Hanks buffer. After determining cell survival by trypan-blue exclusion test, the WBC concentration was normalized to 106 cells/ml in Hanks buffer. WBC populations were evaluated by microscopic observation after May-Grunwald-Giemsa staining. Cells were centrifuged for 6 min at 700 g (4°C), and then 100 µl of 1× PBS was immediately added to the pellet. Total RNA was isolated from WBCs with TriReagent (MRC, USA) according to the manufacturer’s protocol. For the methanol measurements, blood samples without anticoagulant were incubated at 4°C for 2 h to allow cell sedimentation to occur, and an equal volume of 10% trichloroacetic acid was then added to the plasma aliquot. The mixture was incubated for 20 min on ice and then centrifuged for 10 min at 16 000 g. Finally, the supernatant was analyzed for methanol content by GC.
Animal experiments
Experiments were performed on male BALB/c mice. The animals had unlimited access to food and water and were kept in cages with a temperature controlled environment (20±1°C) with the lights on from 9 AM to 9 PM. The care of experimental animals was performed in strict accordance with the guidelines of the ‘‘Euroguide on the accommodation and care of animals used for experimental and other scientific purposes’’ (FELASA, 2007). All experimental protocols were approved by the Animal Ethics Committees of the A. N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia (Protocol Registration number 2/12 of 6th February 2012). Euthanasia was performed using carbon dioxide in accordance with the 2000 Report of the AVMA Panel on Euthanasia, and all efforts were made to minimize animal suffering. For all surgical procedures, rats were anesthetized by intraperitoneal injection of 300 mg/kg (12%) chloral hydrate. Additionally, to ensure proper pain relief in the preoperative and postoperative periods, we used repeated topical application of a long-acting local anesthetic bupivacaine ointment. Moribund animals, animals obviously in pain, or animals showing signs of severe and enduring distress were humanely killed. Criteria for making the decision to kill moribund or severely suffering animals, and guidance on the recognition of predictable or impending death, were performed in accordance with the Guidelines for Endpoints in Animal Study Proposals (DHHS NIH Office of Animal Care and Use).
Methanol and ethanol measurements by gas chromatography
The methanol and ethanol contents were determined by GC on a capillary FFAP column (50 m×0.32 mm; Varian Inc., Lake Forest, CA, USA) in a Kristall 2000 gas chromatograph (Eridan, Russia). Liquid samples were measured under the following operating conditions: carrier gas, nitrogen; nitrogen flow, 30 ml/min; air flow, 400 ml/min; hydrogen flow, 40 ml/min; injected volume, 1 µl; injector temperature, 160°C; column temperature, 75°C, column temperature increased at 15°C/min to 150°C; retention time, 6.5 min (methanol) or 6.43 min (ethanol); and flame ionization detector temperature, 240°C.
Formaldehyde measurements by HPLC
The Dionex Ultimate 3000 HPLC system was used, and it consisted of a four-gradient pump, a degasser mobile phase, an automatic injector (autosampler) combined with a column thermostat and a spectrophotometric detector with a variable wavelength detector (with simultaneous detection according to 4 different wavelengths). The selected chromatographic column was the Synergi Hydro-RP, 250 mm×4.6, with a sorbent grain diameter of 4 microns (porosity 80 Å) and a pre-column Security Guard (C18 cartridge, 3 mm diameter) (manufactured by Phenomenex, USA). The stationary phase was silica, and it was grafted with polar groups and end-capped by C18. The mobile phase was a mixture of deionized water and acetonitrile (HPLC grade) in a 50/50 ratio by volume. The mobile phase flow rate was 1 ml/min, the column temperature control was set to 30°C, and the sample injection volume was 20 µl of a pre-washing injector mixture of acetonitrile and water (50/50) plus the sample. The total analysis time was 20 minutes. The detection was conducted on a spectrophotometer flow cell by reading the absorbance at 360 nm (near-UV). This assay was based on the interaction of formaldehyde with an excess of 2,4-dinitrophenylhydrazine in an acidic medium to form the corresponding colored hydrazone product, which was then separated from the remaining components of the solution by chromatography. To obtain the reagent solution, 100 µl of 85% phosphoric acid was added to 20 ml of pure acetonitrile, and then 20 mg of 2,4-dinitrophenylhydrazone hydrochloride was added. To prepare the blank solution, 0.5 ml of deionized water was added to 0.5 ml of reagent solution and stirred. The blank solution accounts for any minor impurities in the 2,4-dinitrophenylhydrazone of the formaldehyde in the reagent that formed during storage (for example, from exposing the formaldehyde to the atmosphere). For the sample measurement, 450 µl of deionized water was added to 50 µl of the test sample and 0.5 ml of reagent solution and stirred. The reaction proceeded at room temperature (22–24°C) for 20 min, after which the solution was injected into the chromatograph. For quantitative analysis, the actual calibration dependence on formaldehyde was determined by using a series of standard solutions. The equation for gradient dependence was S (peak area, arbitrary units) = 14.36×c (formaldehyde concentration in mg/l). R2 = 1, which accounted for the blank experiment. The formula for calculating the formaldehyde content of the samples was C (mg/L) = (Sx–Sblank)/14.36×20, where 14.36 is the calibration coefficient and 20 is the dilution factor.
Human WBC microarrays
RNA was extracted from WBCs with an RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. The Illumina BeadArray with a single-color array (Illumina, San Diego, CA, USA) was used as a microarray platform. For the Illumina BeadArray assay, cRNA was synthesized with an Illumina RNA Amplification Kit (Ambion, Austin, TX, USA) according to the manufacturer’s instructions. In brief, 400 ng of total RNA from WBCs was reverse-transcribed to synthesize first- and second-strand cDNA, which was purified with spin columns and then transcribed in vitro into biotin-labeled cRNA. A 750 ng quantity of biotin-labeled cDNA was hybridized to each Illumina Human NT-12 v.4 BeadChip array (Illumina) at 55°C for 18 h. The hybridized BeadChip was washed and labeled with streptavidin-Cy3 (GE Healthcare) and then scanned with the Illumina BeadStation 500 System (Illumina). The scanned image was imported into BeadStudio software (Illumina) for analysis. Approximately 45,000 transcripts representing twelve whole-genome samples can be analyzed on a single BeadChip. The correlation coefficient for identical RNAs was 0.993–0.998 (r2) in the present study. Data analysis was performed with GenomeStudio software (Illumina) and J-Express 2012. The microarray data has been deposited to GEO database with accession number GSE58350.
Mouse brain microarrays
BALB/c mice were randomly divided into groups of five mice. RNA samples collected from the brain after the mouse inhalation of wounded plant leaves or MeOH vapors were used to generate cDNA. The mice were placed in a five-liter plastic container, which received air that was blown down (150 liters/hour) from the evaporator, a 250 ml flask with wounded leaves rubbed with Celite from the Brassica rapa pekinensis (approximately 1 g), or cotton wool soaked with 200 µl of methanol or water (control). After one hour, the brain samples were collected after decapitation. The RNA concentrations were determined using a Nanodrop ND-1000 spectrophotometer (Isogen Life Sciences, Netherlands). Whole brain homogenates from biological replicates were subjected to RNA isolation using TRIzol (Invitrogen, USA), according to the manufacturer’s instructions. Following isolation, total RNA was purified and concentrated using the RNeasy MinElute Kit (QIAGEN, Hilden, Germany). Total RNA (400 ng) was prepared for microarray using the Illumina TotalPrep RNA Amplification Kit (Ambion, USA). The brain transcriptome was assessed using Illumina MouseRef-8 BeadChip microarrays, which contain 25,600 specific oligonucleotide probes. Arrays were scanned using the Illumina BeadArray Reader and BeadScan software. Data were analyzed using GenomeStudio v.2012 (Illumina, USA) with normalization by Cubic Spline and differential expression analysis using the Illumina Custom algorithm. This analysis generated a list of probes with significant (P<0.05) differences in signal intensity between treated and control mice. Probe annotations from the microarray manifest file were updated using the SOURCE database (http://smd.stanford.edu/cgi-bin/source/sourceSearch) with the listed NCBI transcript accession numbers as the search terms. In cases where the accession number was no longer listed in the database, annotations were updated by aligning the probe sequence against the mouse transcriptome using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Genes were analyzed using the J-Express gene expression analysis software, SAM (Significance Analysis of Microarrays) tool. The microarray data has been deposited to GEO database with accession number GSE58303.
qRT-PCR Analysis of Transcript Concentrations
The RNA concentrations were determined by using a Nanodrop ND-1000 spectrophotometer (Isogen Life Sciences). All RNA samples had a 260∶280 absorbance ratio between 1.9 and 2.1. cDNA was obtained by annealing 2 µg of denatured total RNA with 0.1 µg of random hexamers and 0.1 µg of Oligo-dT. The mixture was then incubated with 200 units of Superscript II reverse transcriptase (Invitrogen, USA) for 50 min at 43°C. qRT-PCR was performed by using the iCycler iQ real-time PCR detection system (Bio-Rad, Hercules, CA, USA). EVA Green master mix (Syntol, Russia) was used to detect the target genes according to the manufacturer's instructions. The thermal profile for EVA Green qRT-PCR included an initial heat-denaturing step at 95°C for 3 min followed by 45 cycles of the following: 95°C for 15 s, an annealing step (Table S5) for 30 sec and 72°C for 30 sec, coupled with fluorescence measurements. Following amplification, the melting curves of the PCR products were monitored from 55–95°C to determine the amplification specificity. Each sample was run in triplicate, with a no-template control added to each run.
Supporting Information
Figure S1.
The methanol change dynamic in blood plasma and saliva after pectin intake. The standard error bars are indicated. ***P<0.001 (Student’s t-test); n.s., not significantly different.
https://doi.org/10.1371/journal.pone.0102837.s001
(TIF)
Figure S2.
A chromatogram picture showing the GC analysis results for ethanol contents in the red wine used for the human volunteer experiments.
https://doi.org/10.1371/journal.pone.0102837.s002
(TIF)
Figure S3.
A chromatogram picture showing the GC analysis results for the methanol content of the red wine used in human volunteer experiments.
https://doi.org/10.1371/journal.pone.0102837.s003
(TIF)
Figure S4.
Methanol change dynamic in blood plasma and saliva after red wine intake. The standard error bars are indicated. ***P<0.001 (Student’s t-test).
https://doi.org/10.1371/journal.pone.0102837.s004
(TIF)
Figure S5.
A chromatogram picture showing the GC analysis results for the methanol content of the 40% ethanol used in human volunteer experiments.
https://doi.org/10.1371/journal.pone.0102837.s005
(TIF)
Figure S6.
Methanol change dynamics in the blood plasma of male and female volunteers after administering 40% ethanol. The standard error bars are indicated. *P<0.05; **P<0.01; ***P<0.001 (Student’s t-test); n.s., not significantly different.
https://doi.org/10.1371/journal.pone.0102837.s006
(TIF)
Figure S7.
Cluster diagram showing the expression of 100 significantly differently expressed WBC genes before and after pectin intake. The genes are organized by hierarchical clustering based on the overall similarity in expression patterns. Red represents a relative expression greater than the median expression level across all samples, and blue represents an expression level lower than the median. White indicates intermediate expression.
https://doi.org/10.1371/journal.pone.0102837.s007
(TIF)
Figure S8.
A biological processes diagram for differentially expressed genes after pectin intake. The genes were analyzed by using the DAVID database (http://david.abcc.ncifcrf.gov).
https://doi.org/10.1371/journal.pone.0102837.s008
(TIF)
Figure S9.
A biological processes diagram for differentially expressed genes after pectin intake. The genes were analyzed with the PANTHER database (http://www.pantherdb.org).
https://doi.org/10.1371/journal.pone.0102837.s009
(TIF)
Figure S10.
A map of MeOH-sensitive proteins from the STRING database (http://string-db.org). Colored lines indicate different sources of evidence for each interaction as follows: yellow line, both proteins are collectively found in PubMed; purple line, the interaction of the two proteins has been demonstrated experimentally; and blue line, proteins are often mentioned together in gene and protein databases.
https://doi.org/10.1371/journal.pone.0102837.s010
(TIF)
Table S1.
The list of human up-regulated genes of volunteers after pectin intake.
https://doi.org/10.1371/journal.pone.0102837.s011
(DOC)
Table S2.
The list of human down-regulated genes of volunteers after pectin intake.
https://doi.org/10.1371/journal.pone.0102837.s012
(DOC)
Table S3.
The list of down-regulated genes in intersection of the Venn diagram circles presented in Figure 5B.
https://doi.org/10.1371/journal.pone.0102837.s013
(DOC)
Table S4.
The list of up-regulated genes in intersection of the Venn diagram circles presented in Figure 5B.
https://doi.org/10.1371/journal.pone.0102837.s014
(DOC)
Author Contributions
Conceived and designed the experiments: YLD. Performed the experiments: TVK IVP AVS VSK EVS. Analyzed the data: YLD AVS. Contributed reagents/materials/analysis tools: GIK. Contributed to the writing of the manuscript: YLD.
References
- 1.
Boyle R (1661) The sceptical chymist: or Chymico-physical doubts & paradoxes, touching the spagyrist's principles commonly call'd hypostatical, as they are wont to be propos'd and defended by the generality of alchymists. Whereunto is praemis'd part of another discourse. London: Printed by J. Cadwell for J. Crooke.
- 2. Dorokhov YL, Komarova TV, Petrunia IV, Frolova OY, Pozdyshev DV, et al. (2012) Airborne signals from a wounded leaf facilitate viral spreading and induce antibacterial resistance in neighboring plants. PLoS Pathogens 8: e1002640.
- 3. Dorokhov YL, Komarova TV, Petrunia IV, Kosorukov VS, Zinovkin RA, et al. (2012) Methanol may function as a cross-kingdom signal. PLoS One 7: e36122.
- 4. Fall R, Benson AA (1996) Leaf methanol–the simplest natural product from plants. Trends in Plant Science 1: 296–301.
- 5. Guenther A, Hewitt C, Erickson D, Fall R, Geron C, et al. (1995) A global model of natural volatile organic compound emissions. J Geophys Res 100: 8873–8892.
- 6. Kang K, Park S, Natsagdorj U, Kim YS, Back K (2011) Methanol is an endogenous elicitor molecule for the synthesis of tryptophan and tryptophan-derived secondary metabolites upon senescence of detached rice leaves. Plant J 66: 247–257.
- 7. Körner E, von Dahl CC, Bonaventure G, Baldwin IT (2009) Pectin methylesterase NaPME1 contributes to the emission of methanol during insect herbivory and to the elicitation of defence responses in Nicotiana attenuata. J Exp Bot 60: 2631–2640.
- 8. Nemeček-Marshall M, MacDonald RC, Franzen JJ, Wojciechowski CL, Fall R (1995) Methanol emission from leaves. Plant Physiol 108: 1359–1368.
- 9. von Dahl CC, Hävecker M, Schlögl R, Baldwin IT (2006) Caterpillar-elicited methanol emission: a new signal in plant-herbivore interactions? Plant J 46: 948–960.
- 10. Voglesonger KM, Holloway JR, Dunn EE, Dalla-Betta PJ, O’Day PA (2001) Experimental abiotic synthesis of methanol in seafloor hydrothermal systems during diking events. Chemical Geology 180: 129–139.
- 11. Williams LB, Canfield B, Voglesonger KM, Holloway JR (2005) Organic molecules formed in a primordial womb. Geology 33: 913–916.
- 12. Williams LB, Holloway JR, Canfield B, Glein CR, Dick JM, et al. (2011) Birth of Biomolecules from the Warm Wet Sheets of Clays Near Spreading Centers. In: Earliest life on earth: habitats, environmrnts and methods of detection Part 1: 79–112.
- 13.
Heikes BG, Chang W, Pilson MEQ, Swift E, Singh HB, et al.. (2002) Atmospheric methanol budget and ocean implication. Global Biogeochemical Cycles 16: 1133, 13 PP.
- 14. Hu L, Millet DB, Mohr MJ, Wells KC, Griffis TJ, et al. (2011) Sources and seasonality of atmospheric methanol based on tall tower measurements in the US Upper Midwest Atmos Chem Phys. 11: 11145–11156.
- 15. Razavi A, Karagulian F, Clarisse L, Hurtmans D, Coheur PF, et al. (2011) Global distributions of methanol and formic acid retrieved for the first time from the IASI/MetOp thermal infrared sounder Atmos Chem Phys. 11: 857–872.
- 16. Hüve K, Christ MM, Kleist E, Uerlings R, Niinemets U, et al. (2007) Simultaneous growth and emission measurements demonstrate an interactive control of methanol release by leaf expansion and stomata. J Exp Bot 58: 1783–1793.
- 17. Levy S, Staehelin LA (1992) Synthesis, assembly and function of plant cell wall macromolecules. Curr Opin Cell Biol 4: 856–862.
- 18. Höög JO, Ostberg LJ (2011) Mammalian alcohol dehydrogenases - a comparative investigation at gene and protein levels. Chem Biol Interact 191: 2–7.
- 19. Andresen H, Schmoldt H, Matschke J, Flachskampf FA, Turk EE (2008) Fatal methanol intoxication with different survival times - morphological findings and postmortem methanol distribution. Forensic Sci Int 179: 206–210.
- 20. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA (2002) American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 40: 415–446.
- 21. Jones A (1987) Elimination half-life of methanol during hangover. Pharmacol Toxicol 60: 217–220.
- 22. Kavet R, Nauss KM (1990) The toxicity of inhaled methanol vapors. Crit Rev Toxicol 21: 21–50.
- 23. Lanigan S (2001) Final report on the safety assessment of methyl alcohol. Int J Toxicol 20 Suppl 157–85.
- 24. Tephly TR (1991) The toxicity of methanol. Life Sci 48: 1031–1041.
- 25. Tulpule K, Dringen R (2013) Formaldehyde in brain: an overlooked player in neurodegeneration? J Neurochem 127: 7–21.
- 26. Wallage HR, Watterson JH (2008) Formic acid and methanol concentrations in death investigations. J Anal Toxicol 32: 241–247.
- 27. Wang JC, Kapoor M, Goate AM (2012) The genetics of substance dependence. Annu Rev Genomics Hum Genet 13: 241–61.
- 28. Thompson CM, Ceder R, Grafström RC (2010) Formaldehyde dehydrogenase: beyond phase I metabolism. Toxicol Lett 193: 1–3.
- 29. Von Burg R (1994) Methanol. J Appl Toxicol 14: 309–313.
- 30. Jones GR, Singer PP, Rittenbach K (2007) The relationship of methanol and formate concentrations in fatalities where methanol is detected. J Forensic Sci 52: 1376–1382.
- 31. Makar AB, Tephly TR (1977) Methanol poisoning. VI. Role of folic acid in the production of methanol poisoning in the rat. J Toxicol Environ Health 2: 1201–1209.
- 32.
McMartin KE, Martin-Amat G, Makar AB, Tephly TR (1977) Methanol poisoning: role of formate metabolism in the monkey. In: Alcohol and Aldehyde Metabolizing Systems, Vol. 2, Thurman RG, Williamson JR, Drott H, Chance B, Eds, Academic Press, New York, pp. 429–439.
- 33. McMartin KE, Martin-Amat G, Noker PE, Tephly TR (1979) Lack of role for formaldehyde in methanol poison ing in the monkey. Biochem Pharmacol 28: 645–649.
- 34. McMartin KE, Sebastian CS, Dies D, Jacobsen D (2012) Kinetics and metabolism of fomepizole in healthy humans. Clin Toxicol (Phila) 50: 375–383.
- 35. Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, et al. (2007) Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol 37: 629–727.
- 36.
Restani P, Galli CL (1991) Oral toxicity of formaldehyde and its derivatives. CRC Crit Rev Toxicol 21, 315–328.
- 37. Eriksen SP, Kulkarni AB (1963) Methanol in Normal Human Breath. Science 141: 639–640.
- 38. Enderby B, Lenney W, Brady M, Emmett C, Spaněl P, Smith D (2009) Concentrations of some metabolites in the breath of healthy children aged 7–18 years measured using selected ion flow tube mass spectrometry (SIFT-MS). J Breath Res 3: 036001.
- 39. Fisher JW, Dorman DC, Medinsky MA, Welsch F, Conolly RB (2000) Analysis of respiratory exchange of methanol in the lung of the monkey using a physiological model Toxicol Sci. 52: 185–193.
- 40. Taucher J, Lagg A, Hansel A, Vogel W, Lindinger W (1995) Methanol in human breath. Alcohol Clin. Exp Res 19: 1147–1150.
- 41. Turner C, Spanel P, Smith D (2006) A longitudinal study of methanol in the exhaled breath of 30 healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas 27: 637–648.
- 42. Turner C, Parekh B, Walton C, Spanel P, Smith D, et al. (2008) An exploratory comparative study of volatile compounds in exhaled breath and emitted by skin using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 22: 526–532.
- 43. Western OC, Ozburn EE (1949) Methanol and formaldehyde in normal body tissues and fluids. U S Nav Med Bull 49: 574.
- 44. Kostic MA, Dart RC (2003) Rethinking the toxic methanol level. J Toxicol Clin Toxicol 41: 793–800.
- 45.
Clary JJ, Sullivan JB Jr. (1999) Formaldehyde. In: Clinical Environmental Health and Toxic Exposures (JB Sullivan and GR Krieger, Eds). Lippincott Williams &Wilkins, Philadelphia PA, pp. 1007–1014.
- 46. Tong Z, Zhang J, Luo W, Wang W, Li F, et al. (2011) Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol Aging 32(1): 31–41.
- 47. Komarova TV, Petrunia IV, Shindyapina AV, Silachev DV, Sheshukova EV, et al. (2014) Endogenous methanol regulates mammalian gene activity. PLoS One 9(2): e90239.
- 48. Axelrod J, Daly J (1965) Pituitary Gland: Enzymic Formation of Methanol from S-Adenosylmethionine. Science 150: 892–893.
- 49. Snyder SH, Axelrod J, Smith OD, Pucci GL (1967) Formation of methanol by an enzyme in an ectopic pinealoma. Nature 215: 773–774.
- 50. Gentilini D, Mari D, Castaldi D, Remondini D, Ogliari G, et al. (2012) Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring. Age (Dordr) 35: 1961–1973.
- 51. Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, et al. (2012) Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A. 109: 10522–10527.
- 52. Zeng J, Konopka G, Hunt BG, Preuss TM, Geschwind D, et al. (2012) Divergent whole-genome methylation maps of human and chimpanzee brains reveal epigenetic basis of human regulatory evolution. Am J Hum Genet. 91: 455–465.
- 53. Schapira M (2011) Structural Chemistry of Human SET Domain Protein Methyltransferases. Curr Chem Genomics 5 (Suppl 1)85–94.
- 54. Diliberto EJ Jr, Axelrod J (1974) Characterization and substrate specificity of a protein carboxymethylase in the pituitary gland. Proc Natl Acad Sci U S A 71: 1701–1704.
- 55. Diliberto EJ Jr, Axelrod J (1976) Regional and subcellular distribution of protein carboxymethylase in brain and other tissues. J Neurochem 26: 1159–1165.
- 56. Diliberto DJ Jr, Veiveros OH, Axelrod J (1976) Subcellualr distribution of protein carboxymethylase and its endogenous substrates in the adrenal medulla: possible role in excitation-secretion coupling. Proc Natl Acad Sci U S A 73: 4050–4054.
- 57. Gagnon C, Axelrod J, Brownstein MJ (1978) Protein carboxymethylation: effects of 2% sodium chloride administration on protein carboxymethylase and its endogenous substrates in rat posterior pituitary. Life Sciences 22: 2155–2164.
- 58. Wolf ME, Roth RH (1985) Dopamine autoreceptor stimulation increases protein carboxyl methylation in striatal slices. J Neurochemistry 44: 291–298.
- 59. Rycerz K, Jaworska-Adamu JE (2013) Effects of aspartame metabolites on astrocytes and neurons. Folia Neuropathol. 2013 51(1): 10–7.
- 60.
Soffritti M, Padovani M, Tibaldi E, Falcioni L, Manservisi F, et al.. (2014) The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation. Am J Ind Med. 2014 Jan 16. doi: 10.1002/ajim.22296. [Epub ahead of print].
- 61. Lester D (1962) The concentration of apparent endogenous ethanol. Q J Stud Alcohol 23: 17.
- 62. Marmot M, Brunner E (1991) Alcohol and cardiovascular disease: the status of the U shaped curve. BMJ 303: 565–568.
- 63. Monte WC (1984) Aspartame, methanol and the public health. J Appl Nutr 36: 42–58.
- 64. San José B, van de Mheen H, van Oers JA, Mackenbach JP, Garretsen HF (1999) The U-shaped curve: various health measures and alcohol drinking patterns. J Stud Alcohol 60: 725–731.
- 65. Jacobsen D, McMartin KE (1986) Methanol and ethylene glycol poisonings: Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1: 309–334.
- 66. Jacobsen D, Ovrebo S, Aroesen E, Paus PN (1983) Pulmonary excretion of methanol in man, Scand J Clin Lab Invest. 43(5): 377–379.
- 67. Baud FJ, Bismuth C, Garnier R, Galliot M, Astier A, et al. (1987) 4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in man. J Toxicol Clin Toxicol 24: 463–483.
- 68. Baud FJ, Galliot M, Astier A, Bien DV, Garnier R, et al. (1988) Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. N Engl J Med 319: 97–100.
- 69. Sarkola T, Eriksson CJ (2001) Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans. Alcohol Clin Exp Res 25: 513–516.
- 70. Galli A, Price D, Crabb D (1999) High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced. HeLa cells. Hepatology 29: 1164–1170.
- 71. Matsumoto M, Cyganek I, Sanghani PC, Cho WK, Liangpunsakul S, et al. (2011) Ethanol metabolism by HeLa cells transduced with human alcohol dehydrogenase isoenzymes: control of the pathway by acetaldehyde concentration. Alcohol Clin Exp Res 35: 28–38.
- 72. Xiao Q, Weiner H, Johnston T, Crabb DW (1995) The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells. J Clin Invest 96: 2180–2186.
- 73. Butterfield DA, Hardas SS, Lange ML (2010) Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. J Alzheimers Dis 20: 369–393.
- 74. Cumming RC, Schubert D (2005) Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J 19: 2060–2062.
- 75. Sirover MA (2005) New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 95: 45–52.
- 76. Minjarez B, Valero Rustarazo ML, Sanchez del Pino MM, González-Robles A, Sosa-Melgarejo JA, et al. Identification of polypeptides in neurofibrillary tangles and total homogenates of brains with Alzheimer's disease by tandem mass spectrometry. J Alzheimers Dis 34: 239–262.
- 77. Attar N, Cullen PJ (2010) The retromer complex. Adv Enzyme Regul 50: 216–236.
- 78. van WeeringJR, Verkade P, Cullen PJ (2010) SNX-BAR proteins in phosphoinositide-mediated, tubular-based endosomal sorting. Semin Cell Dev Biol 21: 371–380.
- 79. Schöbel S, Neumann S, Hertweck M, Dislich B, Kuhn PH, et al. (2008) A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein. J Biol Chem 283: 14257–1468.
- 80. Steinberg F, Heesom KJ, Bass MD, Cullen PJ (2012) SNX17 protects integrins from degradation by sorting between lysosomal and recycling pathways. J Cell Biol 197: 219–230.
- 81. Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA (2012) The human circadian metabolome. Proc Natl Acad Sci U S A 109: 2625–2629.
- 82. Habauzit V, Morand C (2012) Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther Adv Chronic Dis 3: 87–106.
- 83. Pasinetti GM (2013) Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications. Planta Med 79: 1614–1619.
- 84. Kim JR, Lee SR, Chung HJ, Kim S, Baek SH, et al. (2003) Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity. Exp Mol Med 35: 403–411.
- 85. Lucas HR, Rifkind JM (2013) Considering the vascular hypothesis of Alzheimer's disease: effect of copper associated amyloid on red blood cells. Adv Exp Med Biol. 765: 131–138.
- 86. Chuang J-Y, Lee C-W, Shih Y-H, Yang T, Yu L, et al. (2012) Interactions between Amyloid-b and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer’s Disease. PLoS ONE 7: e33120.
- 87. Ferrer I, Gómez A, Carmona M, Huesa G, Porta S, et al. (2011) Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies. J Alzheimers Dis 23: 537–550.
- 88. Blom ES, Wang Y, Skoglund L, Hansson AC, Ubaldi M, et al. (2011) Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain. Int J Alzheimers Dis 2011: 936580.
- 89. Wilkinson K, Boyd JD, Glicksman M, Moore KJ, El Khoury J (2011) A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36. J Biol Chem 286: 34914–3422.
- 90. Buggins AG, Levi A, Gohil S, Fishlock K, Patten PE, et al. (2011) Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Br J Haematol 154: 216–222.
- 91. Dafnis I, Tzinia AK, Tsilibary EC, Zannis VI, Chroni A (2012) An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines. Neuroscience 210: 21–32.
- 92. Wilcock DM, Morgan D, Gordon MN, Taylor TL, Ridnour LA, et al. (2011) Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence. J Neuroinflammation 8: 115.
- 93. Kavathia N, Jain A, Walston J, Beamer BA, Fedarko NS (2009) Serum markers of apoptosis decrease with age and cancer stage. Aging (Albany NY) 1: 652–663.
- 94. Yasuhara O, Matsuo A, Terai K, Walker DG, Berger AE, et al. (1997) Expression of interleukin-1 receptor antagonist protein in post-mortemhuman brain tissues of Alzheimer's disease and control cases. Acta Neuropathol 93: 414–420.
- 95. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ (2010) Differential regulation of interleukin-1 receptor-associated kinase-1(IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressedhuman astroglial cells and in Alzheimer disease. J Biol Chem 285: 38951–38960.
- 96. Yuan J, Luo K, Zhang L, Cheville JC, Lou Z (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140: 384–396.
- 97. Richards G, Messer J, Malherbe P, Pink R, Brockhaus M, et al. (2005) Distribution and abundance of metabotropic glutamate receptor subtype2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPgammas binding. J Comp Neurol 487: 15–27.
- 98. Mohlake P, Whiteley CG (2010) Arginine metabolizing enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol Neurobiol 41: 149–58.
- 99. Suo WZ, Li L (2010) Dysfunction of G protein-coupled receptor kinases in Alzheimer's disease. ScientificWorldJournal 10: 1667–1678.
- 100. Pacheco-Quinto J, Herdt A, Eckman CB, Eckman EA (2013) Endothelin-Converting Enzymes and Related Metalloproteases inAlzheimer's Disease. J Alzheimers Dis 33 Suppl 1S101–110.
- 101. Nalivaeva NN, Belyaev ND, Zhuravin IA, Turner AJ (2012) The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it? Int J Alzheimers Dis 2012: 383796.
- 102. Wilhelmus MM, de Jager M, Rozemuller AJ, Brevé J, Bol JG, et al. (2012) Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. J Pathol 226: 132–142.
- 103. Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A, et al. (2011) Impact of SORL1 single nucleotide polymorphisms on Alzheimer'sdisease cerebrospinal fluid markers. Dement Geriatr Cogn Disord 32: 164–170.
- 104. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, et al. (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39: 168–177.
- 105. Tan Z, Sun X, Hou FS, Oh HW, Hilgenberg LG, et al. (2007) Mutant ubiquitin found in Alzheimer’s disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ 14: 1721–1732.
- 106. Chadwick L, Gentle L, Strachan J, Layfield R (2012) Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease. Neuropathol Appl Neurobiol 38: 118–131.
- 107. Koury MJ, Sawyer ST, Brandt SJ (2002) New insights into erythropoiesis. Curr Opin Hematol 9: 93–100.
- 108. Tsiftsoglou AS, Vizirianakis IS, Strouboulis J (2009) Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 61: 800–830.
- 109. Lindinger W, Taucher J, Jordan A, Hansel A, Vogel W (1997) Endogenous production of methanol after the consumption of fruit. Alcohol Clin Exp Res 21: 939–943.
- 110. Dragsted LO, Krath B, Ravn-Haren G, Vogel UB, Vinggaard AM, et al. (2006) Biological effects of fruit and vegetables. Proc Nutr Soc 65: 61–67.
- 111. Dwyer JT (1988) Health aspects of vegetarian diets. Am J Clin Nutr 48: 712–738.
- 112. Leclere L, Cutsem PV, Michiels C (2013) Anti-cancer activities of pH- or heat-modified pectin. Front Pharmacol 4: 128.
- 113. Ravn-Haren G, Dragsted LO, Buch-Andersen T, Jensen EN, Jensen RI, et al. (2012) Intake of whole apples or clear apple juice has contrasting effects on plasmalipids in healthy volunteers. Eur J Nutr 52: 1875–1889.
- 114. Gallaher CM, Gallaher DD (2003) Dried plums (prunes) reduce atherosclerosis lesion area in apolipoprotein E-deficient mice. Br J Nutr 101: 233–239.
- 115. Lampe JW (1999) Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr 70: 475S–90S.
- 116. Allès B, Samieri C, Féart C, Jutand MA, Laurin D, et al. (2012) Dietary patterns: a novel approach to examine the link between nutritionand cognitive function in older ind-ividuals. Nutr Res Rev 4: 1–16.
- 117. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, et al. (2012) Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res 37: 1829–1842.
- 118. Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N (2012) Nutrient intake and plasma β-amyloid. Neurology 78: 1832–1840.
- 119. Loef M, Walach H (2012) Fruit, vegetables and prevention of cognitive decline or dementia: à systematic review of cohort studies. J Nutr Health Aging. 2012 16(7): 626–630.
- 120. Luchsinger JA, Noble JM, Scarmeas N (2007) Diet and Alzheimer’s disease. Curr Neurol Neurosci Rep 7: 366–372.
- 121. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, et al. (2009) Physicochemical determinants of human renal clearance. J Med Chem. 52: 4844–4852.
- 122. Jacobsen D, Sebastian CS, Dies DF, Breau RL, Spann EG, et al. (1996) Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. Alcohol Clin Exp Res 20: 804–809.
- 123. Thambisetty M, Lovestone S (2010) Blood-based biomarkers of Alzheimer’s disease: challenging but feasible. Biomark Med 4: 65–79.
- 124. Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, et al. (2011) Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease. Neurobiol Dis 43: 698–705.
- 125. Cristalli DO, Arnal N, Marra FA, de Alaniz MJ, Marra CA (2012) Peripheral markers in neurodegenerative patients and their first-degree relatives. Neurol Sci 314: 48–56.
- 126. Kálmán J, Kitajka K, Pákáski M, Zvara A, Juhász A, et al. (2005) Gene expression profile analysis of lymphocytes from Alzheimer's patients. Psychiatr Genet 15: 1–6.
- 127. Mandas A, Abete C, Putzu PF, la Colla P, Dessì S, et al. (2012) Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients Lipids Health Dis. 11: 39–47.
- 128. Dumeaux V, Olsen KS, Nuel G, Paulssen RH, Børresen-Dale A-L, et al. (2010) Deciphering Normal Blood Gene Expression Variation–The NOWAC Postgenome Study. PLoS Genet 6: e1000873.
- 129. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, et al. (2005) Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 22: 402–411.
- 130. Leonardson AS, Zhu J, Chen Y, Wang K, Lamb JR, et al. (2010) The effect of food intake on gene expression in human peripheral blood. Hum Mol Genet 19: 159–169.
- 131. Curley G, Laffey JG, Kavanagh BP (2010) Bench-to-bedside review: carbon dioxide. Crit Care 14: 220.
- 132. Huang M, Kamasani U, Prendergast GC (2006) RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3. Oncogene 25: 1281–1289.